Healthcare startup RED.Health raises $20 mn led by Jungle Ventures
2 Min Read

Medical emergency response platform RED.Health on Wednesday said that it raised $20 million in its Series B funding led by the venture capital firm Jungle Ventures.

The round also saw participation from existing and new investors including HealthQuad, HealthX, and Alteria Capital.

“Since our last fundraise, we’ve made substantial strides in technology development, particularly in refining our dispatch system to ensure seamless operations without delays or errors. With this round, we’re set to scale operations in becoming the only integrated medical emergency response platform in India,” Prabhdeep Singh, Founder and CEO of RED.Health, said in a statement.

As per the company, the new capital will fuel RED.Health’s innovation pipeline allows for investments in developing technology-driven solutions for the emergency value chain, such as an auto-dispatch system that will minimise human errors and optimize response time.

The company’s AI-powered triage allows for the right hospital selection and immediate vital sharing with the first responders. It aims to deploy its state technology across hospitals and employers in India, on top of its full-stack response system.

“We believe in RED.Health’s vision to expand its services to more than 40 cities in India, leveraging technology to enable the nearest ambulance to transport a patient safely to one’s hospital of choice. We foresee that in the long term, every Indian should be able to access emergency response via just a click of a button,” said Seemant Jauhari, Partner, Healthcare, at Jungle Ventures.

Since its inception in 2016, RED.Health has expanded its technology and solution portfolio to cover many emergency scenarios and modes of transportation, such as air and road ambulances.

The company presently has an impressive fleet of 450 managed ambulances. Additionally, its extensive network comprises 6,000 Saathi road ambulances and 10 aircraft dedicated to air ambulance services.

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *